Imagine the day when you will simply spit on a piece of paper to test yourself for the flu. Similar to the way home pregnancy tests kits are used now. The possibility that simple, point-of-sale consumer diagnostics could be mass marketed for a variety of diseases will not only will it change how the pharmaceutical industry delivers treatments, it will also transform the hallowed doctor-patient relationship.
Join us for lunch on May 3 to hear Dr. Andrew Ellington, a professor of chemistry and biochemistry at the University of Texas, describe his research using DNA computation to develop innovative point-of-care diagnostics. He will talk about how far hiss research has come, and what the future holds.